...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Est. Cash Position
4
Apr 26, 2021 06:31PM

Thanks for all of this information! Not much $$$ here either!

$1.5 million loan and they canceled the reversionary right for Newsoara?

That doesn't sound good! What's your take, given it's non-interest bearing?

5
Apr 26, 2021 07:14PM
2
Apr 26, 2021 08:19PM
4
Apr 27, 2021 10:18AM
Share
New Message
Please login to post a reply